drugset

drugset / Trial / NCT00375401

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

NCT00375401 ↗

Phase 3 Terminated 2536 enrolled Pfizer

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine the long-term weight loss and safety of CP-945,598 in obese adults

Timeline

Start: 2006-10
Primary completion: 2009-01
Completion: 2009-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	OTENABANT	Small molecule	—	—

Indications